Home/Filings/4/0001628280-25-023989
4//SEC Filing

George Jeffrey P. 4

Accession 0001628280-25-023989

CIK 0001723128other

Filed

May 7, 8:00 PM ET

Accepted

May 8, 6:57 PM ET

Size

9.1 KB

Accession

0001628280-25-023989

Insider Transaction Report

Form 4
Period: 2025-05-05
Transactions
  • Award

    Restricted Stock Units

    2025-05-06+34,81934,819 total
    Class A Common Stock (34,819 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2025-05-05+40,258309,795 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-05-0540,2580 total
    Class A Common Stock (40,258 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F2]On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.
  • [F3]Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

Issuer

Amneal Pharmaceuticals, Inc.

CIK 0001723128

Entity typeother

Related Parties

1
  • filerCIK 0001796789

Filing Metadata

Form type
4
Filed
May 7, 8:00 PM ET
Accepted
May 8, 6:57 PM ET
Size
9.1 KB